17000

🔥 CPT 17000 — Destruction, Premalignant Lesion(s); First Lesion

Quick Reference

wRVU: 0.61 | Global Period: 010 (10 days) | Assistant Payable: ❌ No | Bilateral Indicator: 1

---

📋 Clinical Description

CPT 17000 describes the destruction of the first premalignant skin lesion using any recognized destructive modality — including cryosurgery (liquid nitrogen), electrosurgery, laser surgery, chemical destruction, or surgical curettement. This code covers only the first lesion treated at a single encounter; additional lesions 2 through 14 are each reported with one unit of 17003, and 15 or more lesions in a single session are reported with 17004 instead of 17000 + 17003 stacking. The key differentiator between this family and the malignant excision family (11640-11646) is that 17000 is used for premalignant lesions (e.g., actinic keratoses) — confirmed malignancies require excision codes or Mohs surgery.

Actinic keratosis (AK) — the most common diagnosis driving this code — is a squamous intraepithelial lesion caused by cumulative UV exposure that induces dysplastic changes in keratinocytes of the epidermis. AKs are considered obligate premalignant lesions with an estimated 0.1-10% annual risk of progression to invasive squamous cell carcinoma if left untreated; destruction is the standard of care for clinically identified discrete lesions. When a lesion that appeared to be an AK is biopsied and returns as invasive SCC or BCC, the diagnosis shifts to a malignant code family — C44.- — and the excision or Mohs codes become appropriate rather than 17000.

This procedure may be performed in the following clinical contexts:

• Isolated actinic keratosis, single lesion — The classic 17000 scenario; one discrete AK treated with cryotherapy in a single freeze-thaw cycle; the 10-day global period applies from the date of service.
• First AK in a session where 2-14 total AKs are treated — Report 17000 for the first lesion, then one unit of 17003 per additional lesion through the 14th; the two codes are always reported together in this scenario.
• Periocular or eyelid AK — AKs on or near the eyelid margin may be treated by an ophthalmologist or oculoplastic surgeon; laterality modifiers (-RT/-LT) and eyelid modifiers (-E1--E4) apply when the site is specifically the eyelid.
• AK treatment concurrent with a separately identifiable E/M service — When the provider evaluates a new problem or performs a clinically distinct medical decision-making service on the same date as AK destruction, modifier -25 on the E/M code supports separate billing.
• Recurrent AK following prior treatment — Retreatment of a previously treated AK that has clinically recurred; document the recurrence explicitly in the medical record to support medical necessity for repeat treatment.

---

🔬 Anatomical & Procedural Considerations

Modality	Mechanism / Steps	Key Notes
Cryotherapy (Liquid Nitrogen)	Liquid nitrogen applied via spray or cotton tip applicator; freeze-thaw cycle induces intracellular ice crystal formation and keratinocyte death	Most common U.S. technique; typical freeze time 5-10 seconds per lesion; single freeze-thaw cycle standard for AK; the op note must document the modality and site — “cryotherapy applied to AK, [site]“
Electrosurgery	High-frequency electrical current destroys tissue via heat coagulation; curettement may follow to remove necrotic material	Requires documentation of tissue destruction rather than excision — if the lesion is excised (cut out), report an excision code; electrodesiccation + curettage = still 17000 when applied to premalignant lesion
Laser Surgery	Ablative laser (CO₂ or Er:YAG) vaporizes the epidermis including the dysplastic cells; used for field treatment or discrete lesions	Laser modality does not change the code — 17000 applies regardless of whether laser, cryo, or electrosurgery is used; modality must be documented
Chemical Destruction	Topical caustic agent (e.g., trichloroacetic acid) applied to the lesion surface to induce controlled chemical necrosis	Less common for single-lesion discrete treatment; field therapy agents (5-FU, imiquimod) applied by the patient at home are NOT reported with 17000 — these are medication management encounters
Surgical Curettement	Mechanical scraping of the lesion with a curette to remove dysplastic epidermis	When curettement is the sole modality for an AK (not a malignant lesion), 17000 applies; if curettement is performed on a confirmed BCC/SCC, the malignant excision or destruction family applies

Clinical Pearl

The 15-lesion threshold rule is the most important counting rule in this family: if 15 or more premalignant lesions are destroyed in a single session, do NOT stack 17000 + multiple units of 17003. Instead, report 17004 alone — it is the flat-rate code covering destruction of 15 or more lesions and replaces the entire 17000/17003 combination for high-volume sessions. Many practices routinely miscount and report 17000 + 14 units of 17003 when 15 total lesions were treated — this is incorrect and will flag on NCCI audit. Count all lesions destroyed in the session before selecting the code family.

---

✅ Procedure Includes

• Pre-procedure clinical identification and marking of the lesion(s) to be treated
• Skin preparation at the treatment site (alcohol cleansing, etc.)
• Application of the destructive modality (cryo, electro, laser, chemical, or curette) to the first premalignant lesion
• One standard freeze-thaw cycle when cryotherapy is performed (additional cycles may support medical necessity documentation but do not change the code)
• Routine wound care at the treatment site following destruction
• Standard post-procedure instructions provided to the patient
• Documentation of modality used, lesion site(s), and count of lesions treated — required for audit defense and for selection of 17000 vs. 17003 vs. 17004

---

❌ Excludes / Do Not Report Together

Code	Description	Relationship to 17000
17003	Destruction, premalignant lesions; second through 14th lesion, each	Add-on code — reported in addition to 17000 when 2-14 total lesions are destroyed in the session; NOT reported alone; always requires 17000 as the primary code
17004	Destruction, premalignant lesions; 15 or more lesions	Replaces the 17000 + 17003 combination entirely when 15 or more premalignant lesions are destroyed in one session; mutually exclusive with 17000 in the same session
17110	Destruction, benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions	Different code family — use 17110/17111 for BENIGN lesions (e.g., seborrheic keratoses, verrucae); 17000 is specifically for PREMALIGNANT lesions; do not interchange
11640-11646	Excision, malignant lesion, face, ears, eyelids, nose, lips	When a lesion confirmed as malignant (BCC, SCC, melanoma) requires surgical excision with margins, the excision family applies — 17000 is not appropriate for confirmed malignancies
17311-17315	Mohs micrographic surgery	When Mohs technique is used for a malignant lesion, the Mohs code family entirely replaces any destruction code
E/M codes (992xx / 920xx)	Office visit, any level	Separately reportable only when modifier -25 is appended to the E/M code, documenting a significant, separately identifiable E/M service beyond the routine pre-procedure assessment for AK

Bundling Alert — Global Period is 010, Not 090 or 000

CPT 17000 carries a 10-day global surgical package — significantly shorter than the 90-day global for malignant excision codes like 11646. All routine post-procedure wound checks and follow-up related to the AK destruction within 10 days are bundled. After Day 10, E/M services for unrelated conditions are separately billable without a modifier. The most common billing error in this family is assuming a 000 (same-day) or 090 (90-day) global applies — particularly when 17000 is billed alongside a -25 E/M and the follow-up visit falls within Day 1-10 and is mistakenly billed separately. For unrelated E/M visits within the 10-day global window, append modifier -24 to the E/M code and document the unrelated nature.

---

🌳 Code Tree — Surgery: Integumentary System, Destruction - Premalignant & Benign Lesions

CPT 17000-17286 Destruction — Skin Lesions  
│  
├── 17000-17004 Destruction — Premalignant Lesions  
│ ├── ▶▶ 17000 ◀◀ Premalignant lesion; first lesion ← YOU ARE HERE (Global: 010)  
│ ├── 17003 Second through 14th lesion, each (add-on) (Global: N/A — add-on)  
│ └── 17004 15 or more lesions (Global: 010)  
│  
├── 17106-17108 Destruction — Cutaneous Vascular Proliferative Lesions  
│ ├── 17106 Less than 10 sq cm  
│ ├── 17107 10.0-50.0 sq cm  
│ └── 17108 Over 50.0 sq cm  
│  
├── 17110-17111 Destruction — Benign Lesions (not skin tags or vascular)  
│ ├── 17110 Up to 14 lesions  
│ └── 17111 15 or more lesions  
│  
└── 17250 Chemical Cauterization of Granulation Tissue

---

💰 RVU & Reimbursement Profile

Component	Value
Work RVU (wRVU)	0.61 (verify against current CMS MPFS for applicable year)
Global Period	010 (10 days)
Bilateral Indicator	1 — Subject to standard 150% bilateral payment adjustment rules
Assistant Surgeon	❌ Not payable
Co-Surgeon	❌ Not applicable
Team Surgery	❌ Not applicable
PC/TC Split	❌ No — procedure code only (Indicator 0)
Modifier -51 Exempt	No — 17003 is the add-on code that is modifier-51 exempt; 17000 itself is not -51 exempt
Anesthesia	Local topical or infiltration anesthesia included; no separate anesthesia billing expected

Bilateral Billing Rules

CPT 17000 has a bilateral indicator of 1, subject to 150% bilateral payment adjustment when the same-size-tier destruction is performed bilaterally in the same session. In practice, AK destruction is almost never a true bilateral procedure by the strict definition — lesions on both sides of the face are counted individually toward the lesion total and drive the 17000/17003/17004 selection. Bilateral reduction more commonly becomes relevant when treating paired anatomic structures (e.g., both ears). Count each discrete lesion toward the total count regardless of laterality; use -RT/-LT modifiers to document site when clinically relevant (particularly for eyelid lesions).

---

🏷️ Modifier Reference

Modifier	Name	When to Apply
-RT	Right Side	When AK destruction is performed on a right-sided structure (right ear, right eyelid, right hand) and laterality is clinically significant
-LT	Left Side	When AK destruction is performed on a left-sided structure
-E1	Upper Left Eyelid	When the AK is specifically on the upper left eyelid skin — use in addition to LT for ophthalmology billing
-E2	Lower Left Eyelid	When the AK is specifically on the lower left eyelid skin
-E3	Upper Right Eyelid	When the AK is specifically on the upper right eyelid skin
-E4	Lower Right Eyelid	When the AK is specifically on the lower right eyelid skin
-25	Significant, Separately Identifiable E/M	Applied to the E/M code — not 17000 — when an office visit with distinct medical decision-making is performed on the same date; the E/M must address a condition separate from the routine AK treatment assessment
-24	Unrelated E/M During Postoperative Period	Applied to the E/M code when the patient returns within the 10-day global window for a condition unrelated to the AK destruction; document the unrelated nature explicitly
-51	Multiple Procedures	When 17000 is performed with other surgical procedures at the same session; apply to the lower-valued code; note that 17003 as an add-on code is modifier-51 exempt
-59	Distinct Procedural Service	When payers inappropriately bundle 17000 with another procedure; documents distinct anatomic site or service
-52	Reduced Services	Procedure partially completed — document reason
-53	Discontinued Procedure	Procedure stopped due to patient safety concern — document thoroughly

---

🩺 Common ICD-10-CM Pairings

Primary — Actinic Keratosis and Premalignant Skin Changes

ICD-10 Code	Description	HCC?	Clinical Notes
L57.0	Actinic keratosis	❌ No	Primary diagnosis for the vast majority of 17000 encounters; no laterality or site specificity required at this code level — document lesion site(s) in the clinical note for audit support even though ICD-10 does not require it at this code
L57.1	Actinic reticuloid	❌ No	Chronic photosensitivity disorder with AK-like features; less common; requires dermatologist documentation of this specific diagnosis
L57.8	Other skin changes due to chronic exposure to nonionizing radiation	❌ No	Use when the provider documents UV-induced premalignant skin changes that do not specifically meet the AK descriptor; includes poikiloderma of Civatte and related entities
L57.9	Skin changes due to chronic exposure to nonionizing radiation, unspecified	❌ No	Least specific — use only when documentation does not support L57.0-L57.8; query provider before defaulting to unspecified

Associated / Contributing Diagnosis Codes

ICD-10 Code	Description	HCC?	Clinical Notes
Z85.828	Personal history of other malignant neoplasm of skin	❌ No	Report as additional diagnosis when prior skin cancer history is documented and supports medical necessity for proactive AK treatment; commonly present in dermatology patients with high sun damage burden
Z77.098	Contact with and (suspected) exposure to other hazardous, chiefly nonmedicinal, chemicals	❌ No	Report when UV/occupational sun exposure is explicitly documented as a contributing factor — most relevant for outdoor workers; supports medical necessity narrative
L55.9	Sunburn, unspecified	❌ No	Occasionally documented concurrently when acute UV exposure is also addressed; typically not the primary driver for AK treatment

Eyelid-Specific AK Codes (Ophthalmology Context)

ICD-10 Code	Description	HCC?	Clinical Notes
H02.731	Vitiligo of right upper eyelid and periocular area	❌ No	Not AK-specific — included for awareness; eyelid AKs code to L57.0 regardless of periocular location; H02.- codes are for eyelid structural disorders, not premalignant skin lesions
L57.0	Actinic keratosis	❌ No	L57.0 applies even when the AK is on the eyelid — there is no eyelid-specific AK code within the L57 category; use -RT/-LT and -E1—E4 modifiers on the CPT side to capture anatomic specificity

Coding Specificity Reminder

ICD-10-CM category L57 does not require laterality or anatomic site specificity at the code level — L57.0 is a valid, fully billable code without a 7th character or site designation. However, the clinical documentation must identify the lesion site(s) for audit support and medical necessity purposes. The number of lesions documented and treated drives the CPT code selection (17000, 17003, or 17004) — make sure the medical record clearly counts each lesion treated, as this is the most frequently challenged element on payer review.

---

🏥 MS-DRG Considerations (Inpatient)

****> [!important] Inpatient Coding Reminder

CPT 17000 is performed exclusively in the outpatient or office setting. There are no routine MS-DRG assignments for this procedure — inpatient admission for AK destruction would not be supported by any payer, MAC, or utilization review body. If a patient undergoing an inpatient admission for an unrelated diagnosis also has AK destruction performed, an ICD-10-PCS code may be assigned for completeness, but it will have no meaningful impact on DRG grouping. Refer to the PCS section below for applicable codes.

---

🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)

Note

Inpatient PCS coding for AK destruction is exceedingly uncommon and will rarely affect DRG assignment. The PCS root operation is Destruction (5) — physical eradication of all or a portion of a body part by direct use of energy, force, or destructive agent — consistent with cryotherapy, electrosurgery, or laser ablation of a skin lesion. Destruction is the correct root operation when no tissue is removed and sent for pathology (as opposed to Excision, which involves cutting out a portion of the body part). Assign separate PCS code lines for distinct anatomic sites when multiple sites are treated.

PCS Code	Full Description	Applicable Modality
0H51XZZ	Destruction of Face Skin, External Approach, No Device, No Qualifier	Cryotherapy, electrosurgery, laser, or chemical destruction of facial skin AK
0H52XZZ	Destruction of Right Ear Skin, External Approach, No Device, No Qualifier	AK destruction, right auricular/periauricular skin
0H53XZZ	Destruction of Left Ear Skin, External Approach, No Device, No Qualifier	AK destruction, left auricular/periauricular skin
0H54XZZ	Destruction of Right Upper Eyelid, External Approach, No Device, No Qualifier	AK destruction, right upper eyelid skin
0H55XZZ	Destruction of Left Upper Eyelid, External Approach, No Device, No Qualifier	AK destruction, left upper eyelid skin
0H50XZZ	Destruction of Scalp Skin, External Approach, No Device, No Qualifier	AK destruction, scalp

PCS Character Analysis — 0H51XZZ

Position	Character	Value	Definition
1	Section	0	Medical and Surgical
2	Body System	H	Skin and Breast
3	Root Operation	5	Destruction (physical eradication of all or a portion of a body part by direct use of energy, force, or destructive agent)
4	Body Part	1	Skin, Face
5	Approach	X	External (procedures performed directly on the skin surface)
6	Device	Z	No Device
7	Qualifier	Z	No Qualifier

PCS Root Operation: Destruction (5) vs. Excision (B)

• Use Destruction (5) when the lesion is eradicated in place using energy, cold, or chemical means — no tissue specimen is removed for pathology; this is the correct root operation for cryotherapy, electrodesiccation, and laser ablation of AKs.
• Use Excision (B) when a portion of the skin body part is cut out and removed — applicable when a biopsy or shave removal is performed rather than in-situ destruction.
• When multiple AKs are destroyed at different anatomic sites, assign separate PCS code lines for each distinct body part value — PCS does not have an equivalent to the CPT “per lesion” counting methodology; site-level granularity drives code selection.

---

📝 Coding Examples

---

Example 1 — Office: Single AK, Cryotherapy, with Separate E/M

Clinical Scenario: A 67-year-old established female patient presents to her dermatologist for a routine skin check. During the exam, the physician documents a new actinic keratosis on the right cheek and treats it with liquid nitrogen cryotherapy (one freeze-thaw cycle, approximately 8 seconds). The physician also separately evaluates the patient’s new complaint of a pruritic rash on the forearm — documented with its own history, exam, and assessment/plan — and prescribes triamcinolone cream. Total: 1 AK treated.

Field	Code	Rationale
CPT 1	17000	First premalignant lesion destroyed; cryotherapy modality; single AK on the right cheek
CPT 2	99213-25	Established patient E/M, low complexity; modifier -25 on the E/M code for the separately identifiable evaluation of the new forearm rash; NOT appended to 17000
PDx	L57.0	Actinic keratosis — primary reason for the procedure
SDx	L30.9	Dermatitis, unspecified — diagnosis supporting the separately billed E/M

Note

Modifier -25 belongs on the E/M code (99213), not on 17000. The E/M documentation must independently support a separately identifiable service beyond the pre-procedure assessment for the AK — in this case, the forearm rash evaluation is a distinct new problem. If the E/M note only addressed the AK to be treated, the visit is bundled into the minor procedure payment and is not separately billable.

---

Example 2 — Office: Multiple AKs (9 Total), Cryotherapy Session

Clinical Scenario: A 72-year-old male with extensive sun damage history and prior BCC presents for AK treatment. The physician documents and destroys 9 discrete actinic keratoses across the scalp, face, and bilateral forearms using liquid nitrogen. No separate E/M was documented beyond the pre-procedure assessment. The note states: “Cryotherapy performed on 9 AKs — 1 right temporal scalp, 2 left cheek, 1 nose tip, 2 right forearm, 2 left forearm, 1 right ear helix.”

Field	Code	Rationale
CPT 1	17000	First premalignant lesion — required primary code
CPT 2	17003 × 8 units	Lesions 2-9; 8 additional units of the add-on code; report as 17003 with 8 units (or 8 separate line items per payer preference)
PDx	L57.0	Actinic keratosis — primary diagnosis driving all lesion destructions
SDx	Z85.828	Personal history of malignant neoplasm of skin — supports medical necessity for aggressive AK management in a high-risk patient

Warning

Do NOT report 17004 in this scenario — 17004 applies only when 15 or more lesions are destroyed in a single session. With 9 lesions, the correct approach is 17000 (1st lesion) + 17003 × 8 (lesions 2-9). Also note that 17003 is an add-on code — it is modifier-51 exempt and is never reported without 17000. Billing 17003 alone without 17000 as the primary code will result in a claim denial.

---

Example 3 — Office: 15+ AKs — Switch to 17004; Global Period Application

Clinical Scenario: A 78-year-old male presents for a “field day” AK treatment session. The physician documents and destroys 17 discrete actinic keratoses across the scalp, forehead, ears, and dorsal hands using cryotherapy. A suture removal visit is scheduled for 5 days later for an unrelated prior laceration repair. The note clearly counts each lesion site: “17 AKs treated, cryotherapy.”

Field	Code	Rationale
CPT 1	17004	15 or more premalignant lesions in one session — replaces the 17000 + 17003 combination entirely; single flat-rate code for the entire session regardless of exact count above 15
PDx	L57.0	Actinic keratosis
SDx	Z85.828	Personal history of malignant neoplasm of skin — documents risk context and supports medical necessity

Note

Global period reminder: CPT 17004 (like 17000) carries a 10-day global period. The suture removal visit scheduled for Day 5 — while for an unrelated prior laceration repair — falls within the 10-day global window of today’s AK destruction session. Append modifier -24 to the E/M code at the suture removal visit, document in the note that the visit is unrelated to the AK destruction, and keep the wound check for the AK sites bundled. Failure to apply -24 and document the unrelated nature risks claim denial or recoupment.

---

⚠️ Common Coding Pitfalls

• Reporting 17000 + 17003 when 15 or more lesions were treated: The 15-lesion threshold is the most commonly missed counting rule in this family. When 15 or more premalignant lesions are destroyed in a single session, only 17004 is reported — not 17000 + 14 units of 17003. Stacking 17000 + 17003 beyond 13 add-on units (14 total lesions) when a 15th lesion was treated creates an overpayment situation subject to NCCI and RAC audit. Count every lesion treated before selecting the code.

• Reporting 17003 without 17000 as the primary code: 17003 is a CPT add-on code by definition — it has no stand-alone billing value and requires 17000 as the primary code on the same claim. Billing 17003 alone will result in an automatic claim denial. Ensure 17000 always appears as the primary line when 17003 is reported.

• Confusing 17000 (premalignant) with 17110 (benign): CPT 17110 is used for benign lesion destruction (verrucae, seborrheic keratoses, molluscum). CPT 17000 is used for premalignant lesions (actinic keratoses). The diagnosis code drives which family is correct — L57.0 pairs with 17000; B07.- (warts) or L82.- (SK) pair with 17110. Interchanging these codes based on convenience rather than diagnosis is a compliance violation.

• Billing a separate E/M for the pre-procedure assessment without a truly separate service: The pre-procedure evaluation and patient counseling associated with AK destruction is bundled into the 17000 payment. An E/M code with modifier -25 is only separately payable when the provider performs a clinically distinct evaluation beyond deciding to treat the AK — a separately documented problem-focused history, exam, and medical decision-making process for a different condition must be present. “Established patient came in for AK treatment” does not support a -25 E/M.

• Applying -25 to the procedure code instead of the E/M code: Modifier -25 belongs on the E/M service code, never on the 17000. This is among the most frequently cited billing errors in dermatology practice audits. Verify your billing system defaults and staff training to prevent systematic misplacement of this modifier.

• Failing to track the 10-day global window: CPT 17000 carries a 010 global period — shorter than many surgical codes but still active for 10 days. Routine wound checks and follow-up for the treated AK sites within Days 1-10 are bundled. Implement a 10-day flag in your scheduling system on the date of AK destruction to prevent automatic E/M generation for wound-related follow-up within the global window.

---

📎 Sources

¹ AMA CPT 2025 Professional Edition — CPT 17000, 17003, 17004, Surgery: Integumentary System, Destruction-Premalignant Lesions · ² CMS 2025 Medicare Physician Fee Schedule Final Rule (CMS-1807-F) · ³ CMS RVU25A Relative Value Files — wRVU and global period data for CPT 17000 · ⁴ NCCI Policy Manual Chapter 4 (Surgery: Integumentary System), CMS 2025 — bundling rules for destruction and E/M codes · ⁵ ICD-10-CM Official Guidelines for Coding and Reporting FY2026 — Chapter 12: Diseases of the Skin and Subcutaneous Tissue, L57 coding guidance · ⁶ ICD-10-PCS Official Guidelines for Coding and Reporting FY2026 — Root Operation Destruction (5), Body System H (Skin and Breast) · ⁷ CMS Medicare Coverage Database Article A57660 — Billing and Coding: Excision of Malignant Skin Lesions (context for premalignant vs. malignant distinction) · ⁸ AAFP — “Skin Deep: How to Properly Code for Biopsies and Lesion Removal,” Family Practice Management, March 2019 · ⁹ AAPC CPT Code 17000 Reference — aapc.com/codes/cpt-codes/17000 · ¹⁰ Palmetto GBA Jurisdiction M — Global Period and Modifier Policy (2024) · ¹¹ AAPC Dermatology Coding Alert — Premalignant Lesion Destruction Series 17000/17003/17004 Coding Guidelines